Determination of lafutidine in human plasma by high-performance liquid chromatography-electrospray ionization mass spectrometry: Application to a bioequivalence study

Journal of Mass Spectrometry

Volumn 40, Issue 12, 2005, Pages 1637-1643

  Wu, Lili ^a   Zhang, Zunjian ^a   Tian, Yuan ^a   Li, Wei ^a   Xu, Fengguo ^a   Chen, Yun ^b   Wei, Huilin ^b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b INSTITUTE OF DERMATOLOGY   (China)

Author keywords

Bioequivalence; HPLC ESI MS; Lafutidine; Pharmacokinetics; Quantitation

Indexed keywords

CONCENTRATION (PROCESS); DISSOLUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IONIZATION; MASS SPECTROMETRY; PHARMACOKINETICS;

BIOEQUIVALENCE; HPLC/ESI-MS; LAFUTIDINE; QUANTITATION;

BODY FLUIDS;

2 PROPANOL; LAFUTIDINE;

ANALYTIC METHOD; BIOEQUIVALENCE; BLOOD SAMPLING; CONFERENCE PAPER; DRUG DETERMINATION; EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; ION MONITORING; IONIZATION; PHASE SEPARATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STOMACH EMPTYING;

ACETAMIDES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; PIPERIDINES; PYRIDINES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; THERAPEUTIC EQUIVALENCY;

EID: 30044438072     PISSN: 10765174     EISSN: None     Source Type: Journal    
DOI: 10.1002/jms.942     Document Type: Conference Paper

References (7)

1. Itoh H, Naito T, Takeyama M. Lafutidine changes levels of Somatostatin, Calcitonin gene-related Peptide, and Secretin in human plasma[J]. Biol. Pharm. Bull. 2002; 25: 379.
2. 2 receptor antagonist with gastroprotective activity. Nippon Yakurigaku Zasshi 2001; 117: 377.
3. 2 receptor antagonist, in rats and dogs[J]. Eur. J. Clin. Pharmacol. 1993; 235: 245.
4. 2 receptor antagonist, on various experimental gastric and duodenal lesions in rats. Nippon Yakurigaku Zasshi 1992; 99: 401.
5. Nagahama K, Yamato M, Kato S, Takeuchi K. Protective effect of Lafutidine, a Novel H2-receptor antagonist, on reflux esophagitis in rats through capsaicin-sensitive afferent neurons[J]. J. Pharmacol. Sci. 2003; 93: 55.
6. Onodera S, Shibata M, Tanaka M, Inaba N, Yamaura T, Ohnishi H. Gastroprotective activity of FRG-8813, a novel histamine H2-receptor antagonist, in rats. Jpn. J. Pharmacol. 1995; 68: 161.
7. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Guidance for Industry, Bioanalytical Method Validation, May 2001.